Verve Therapeutics
VERV
#7017
Rank
NZ$0.70 B
Marketcap
$8.28
Share price
5.43%
Change (1 day)
-58.50%
Change (1 year)

Verve Therapeutics (VERV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : NZ$0.26 Billion

According to Verve Therapeutics's latest financial reports the company's total liabilities are NZ$0.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Verve Therapeutics - Total liabilities on balance sheet (from 2020 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31NZ$0.24 B19.88%
2022-12-31NZ$0.20 B415.53%
2021-12-31NZ$39.19 M-80.13%
2020-12-31NZ$0.19 B222.43%
2019-12-31NZ$61.17 M